GenixPharmaceucticals Corporation
🇨🇦XTSX.GENXCanadaHealthcare
PriceCA$0.020.00 (0%)
Latest anomalies
Neutral 1 detected in the last 120 days
- High: 4
- Medium: 3
- Low: 0
52-week low: the price is trading close to this level
Current ratio: below the level we flag as a liquidity warning
Quick ratio: below the level we flag as a liquidity warning
Free cash flow margin: collapsed against the prior period
Gross margin: collapsed against the prior period
Free with a Finzer account.
Profile
- Healthcare
- Drug Manufacturers - Specialty & Generic
- Canada
Identity
- Exchange
- TSX Venture Exchange . XTSX
- Type
- Stock
- ISIN
- CA37232A1093
- CUSIP
- 37232A109
Company
- Employees
- 0
- Headquarters
- Vancouver, Canada
- Website
- https://www.genixpharm.com
Market
- Shares outstanding
- 61.2M
- Market cap
- CA$1.18M
Highlights
No high and low reported for today's session.
- Market cap
- CA$1.18M
- EPS LTM
- -CA$0.00calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -13.55calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- CA$1.07K-81.17%down year on year
- Net income
- -CA$87.43K+97.86%up year on year
- Gross margin
- -34.02%-149.31%down year on year
- Free cash flow
- -CA$163.62K+23.7%up year on year
Latest news
News is not sourced for this exchange.
Business summary
GenixPharmaceucticals Corporation is a company in the healthcare sector, listed on TSX Venture Exchange (Canada) under the ticker GENX. Its market capitalisation is CA$1.18M, from 61.2M shares outstanding, as of . Across the 246 trading sessions to the shares traded between CA$0.02 and CA$0.04, and the last close of CA$0.02 sits 0% of the way up that range. The company is headquartered in Vancouver, Canada.
Genix Pharmaceuticals Corporation formulates, manufactures, licenses, and markets life sciences related products with focus on nutraceuticals and pharmaceuticals in Canada. The company develops Flu-X, an anti-viral, anti-flu, and common colds coronavirus oral and spray herbal product; Renochlor, a dietary supplement to support kidney health; and Sucanon, a herbal health supplement to manage blood sugar levels and enhance insulin sensitivity in non-insulin dependent adults. It also markets and sells nutraceuticals and pharmaceutical products, such as bee propolis capsules, calcium liquid softgels, seal oil softgels, marine lipid softgels, Lecithin softgels, fish oil softgels, EPO softgels, and spirulina powder, as well as eye ointments and drops. The company was formerly known as Alta Natural Herbs & Supplements Ltd. and changed its name to Genix Pharmaceuticals Corporation in June 2019. The company was incorporated in 1993 and is based in Vancouver, Canada.